Combined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes

Hormones

Volumn 10, Issue 2, 2011, Pages 125-130

  Touvra, Anna Maria ^a   Volaklis, Konstantinos A ^a   Spassis, Apostolos T ^a   Zois, Christos E ^a   Douda, Helen T ^a   Kotsa, Kalliopi ^b   Tokmakidis, Savvas P ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cytokines; Exercise; Training effects; Transforming growth factor 1; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; METFORMIN; SULFONYLUREA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC EXERCISE; ANTHROPOMETRY; ARM MUSCLE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; FEMALE; FITNESS; HEALTH STATUS; HUMAN; INSULIN RESISTANCE; LEG MUSCLE; MALE; MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; RESISTANCE TRAINING; RISK REDUCTION;

EID: 79959235127     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1302     Document Type: Article

References (37)

1. Spranger J, Kroke A, Möhlig M, et al, 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
2. Dandona P, Aljada A, Bandyopadhyay A, 2004 Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4-7.
3. Libby P, Ridker PM, Maseri A, 2002 Inflammation and atherosclerosis. Circulation 105: 1135-1143.
4. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR, 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565.
5. Ross R, 1999 Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
6. Feinberg MW, Jain MK, Werner F, et al, 2000 Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem 275: 25766-25773.
7. Lutgens E, Gijbels M, Smook M, et al, 2002 Transforming Growth Factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22: 975-982.
8. Grainger DJ, 2004 Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24: 399-404.
9. Mallat Z, Gojova A, Marchiol-Fournigault C, et al, 2001 Inhibition of transforming growth factor-β1 signalling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89: 930-934.
10. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K, 2002 Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease. Coron Artery Dis 13: 139-143.
11. O'Callaghan CJ, Williams B, 2000 Mechanical Strain- Induced Extracellular Matrix Production by Human Vascular Smooth Muscle Cells Role of TGF-b1. Hypertension 36: 319-324.
12. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ, 2001 Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286: 1218-1227.
13. Dela F, 2007 Other adaptations to training/inactivity in type 2 diabetics and other groups with insulin resistance: emphasis on prevention of CHD. Appl Physiol Nutr Metab 32: 602-606.
14. Stewart KJ, 2002 Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA 288: 1622-1631.
15. Colberg SR, Sigal RJ, Fernhall B, et al, 2010 Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 33: 147-167.
16. Boulé NG, Weisnagel SJ, Lakka TA, et al, 2005 Effects of exercise training on glucose homeostasis. The HERITAGE family study. Diabetes Care 28: 120-126.
17. Cuff DJ, Meneilly GS, Martin A, et al, 2003 Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 26: 2977-2982.
18. Sigal RJ, Kenny GP, Boulé NG, et al, 2007 Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147: 357-369.
19. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD, 2006 Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29: 1433-1438.
20. Tokmakidis SP, Zois CE, Volaklis KA, Kotsa K, Touvra AM, 2004 The effects of a combined strength and aerobic exercise program on glucose control and insulin action in women with type 2 diabetes. Eur J Appl Physiol 92: 437-442.
21. Zois CE, Tokmakidis SP, Volaklis KA, et al, 2009 Lipoprotein profile, glycemic control and physical fitness after strength and aerobic training in post-menopausal women with type 2 diabetes. Eur J Appl Physiol 106: 901-907.
22. Pedersen BK, 2006 The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 42: 105-117.
23. Giannopoulou I, Fernhall B, Carhart R, et al, 2005 Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 54: 866-875.
24. Oberbach A, Tönjes A, Klöting N, et al, 2006 Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 154: 577-585.
25. Zoppini G, Targher G, Zamboni C, et al, 2006 Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 16: 543-549.
26. Hering S, Jost C, Schulz H, Hellmich B, Schatz H, Pfeiffer AFH, 2002 Circulating transforming growth factor-β1 (TGF -β1) is elevated in extensive exercise. Eur J Appl Physiol 86: 406-410.
27. Gordon PL, Vannier E, Hamada K, et al, 2006 Resistance training alters cytokine gene expression in skeletal muscle of adults with type 2 diabetes. Int J Immunopathol Pharmacol 19: 739-749.
28. Matthews DR, Hosker JP, Rudenski AS, et al, 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
29. Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ, 2003 Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46: 1071-1081.
30. Church TS, Cheng YJ, Earnest CP, et al, 2004 Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 27: 83-88.
31. Cauza E, Hanusch-Enserer U, Strasser B, et al, 2005 The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil 86: 1527-1533.
32. Jager A, van Hinsbergh VW, Kostense PJ, et al, 1999 Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 19: 3071-3078.
33. Dvoráková-Lorenzová A, Suchánek P, Havel PJ, et al, 2006 The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55: 359-365.
34. Balducci S, Zanuso S, Nicolucci A, et al, 2010 Antiinflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 20: 608-617.
35. Danzig V, Míková B, Kuchynka P, et al, 2010 Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. Physiol Res 59: 385-392.
36. Tammela T, Enholm B, Alitalo K, Paavonen K, 2005 The biology of vascular endothelial growth factors. Cardiovasc Res 65: 550-563.
37. Rafii S, Lyden D, 2003 Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712.